According to Zacks, “Ichor Holdings, Ltd. is engaged in the design, engineering and manufacturing of critical fluid delivery subsystems for semiconductor capital equipment. Ichor Holdings, Ltd. is based in Fremont, United States. “
A number of other equities research analysts have also recently weighed in on ICHR. Northland Securities set a $13.00 price target on Nabriva Therapeutics and gave the company a buy rating in a research note on Wednesday, May 8th. ValuEngine cut Zions Bancorporation NA from a hold rating to a sell rating in a research note on Wednesday, March 20th. B. Riley set a $7.00 price target on Unique Fabricating and gave the company a buy rating in a research note on Thursday, May 16th. BidaskClub upgraded Yandex from a buy rating to a strong-buy rating in a research report on Friday, June 14th. Finally, Cowen reiterated a buy rating and set a $149.00 price objective on shares of Intercept Pharmaceuticals in a research report on Wednesday, May 8th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and four have assigned a buy rating to the company’s stock. Ichor has a consensus rating of Hold and a consensus target price of $27.38.
ICHR opened at $23.97 on Wednesday. Ichor has a 1-year low of $14.23 and a 1-year high of $26.25. The firm has a fifty day simple moving average of $22.60. The company has a current ratio of 2.27, a quick ratio of 1.01 and a debt-to-equity ratio of 0.98. The company has a market cap of $525.92 million, a PE ratio of 11.99 and a beta of 2.70.
Ichor (NASDAQ:ICHR) last posted its quarterly earnings results on Tuesday, May 7th. The technology company reported $0.20 earnings per share for the quarter, missing analysts’ consensus estimates of $0.26 by ($0.06). Ichor had a net margin of 6.07% and a return on equity of 22.62%. The business had revenue of $137.80 million during the quarter, compared to the consensus estimate of $135.39 million. During the same quarter last year, the company posted $1.03 EPS. The firm’s revenue was down 46.6% on a year-over-year basis. Analysts predict that Ichor will post 1.12 earnings per share for the current year.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in ICHR. SevenBridge Financial Group LLC increased its holdings in shares of Ichor by 212.5% during the fourth quarter. SevenBridge Financial Group LLC now owns 3,750 shares of the technology company’s stock valued at $61,000 after acquiring an additional 2,550 shares in the last quarter. Ellis Investment Partners LLC bought a new stake in shares of Ichor during the first quarter valued at approximately $77,000. BNP Paribas Arbitrage SA increased its holdings in shares of Ichor by 75,966.7% during the first quarter. BNP Paribas Arbitrage SA now owns 4,564 shares of the technology company’s stock valued at $103,000 after acquiring an additional 4,558 shares in the last quarter. Oregon Public Employees Retirement Fund bought a new stake in shares of Ichor during the fourth quarter valued at approximately $142,000. Finally, Systematic Financial Management LP bought a new stake in shares of Ichor during the first quarter valued at approximately $160,000. Hedge funds and other institutional investors own 94.27% of the company’s stock.
Ichor Holdings, Ltd. engages in the design, engineering, and manufacture of fluid delivery subsystems and components for semiconductor capital equipment. It primarily offers gas and chemical delivery subsystems that are used in the manufacturing of semiconductor devices. The company's gas delivery subsystems deliver, monitor, and control gases used in semiconductor manufacturing processes, such as etch and deposition; and chemical delivery subsystems blend and dispense the reactive liquid chemistries used in semiconductor manufacturing processes comprising electroplating and cleaning.
Featured Article: What is the Dividend Aristocrat Index?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Ichor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ichor and related companies with MarketBeat.com's FREE daily email newsletter.